|
Hydralazine, Hydrochloride - Concentration/Dosage 20 Mg, Injectable Solution, Ampoule With 1Ml, Packed According To The Product Registration And With Label, Date Of Manufacture And Expiration, Route Of Intramuscular / Intravenous Administration, Hydrochloride - Concentration/Dosage 25 Mg, Dragee, Oral Route Of Administration, Hydrochlorothiazide - Concentration/Dosage 25 Mg, Tablet Pharmaceutical Form, Oral Administration Route, Isosorbide, Dinitrate - Concentration/Dosage 10 Mg, 01/17/2025, Dinitrate - Concentration/Dosage 5 Mg, Sublingual Administration Route, Dinitrate - Concentration/Dosage 20 Mg, Losartan, Potassium - Concentration/Dosage 50 Mg, Oral Administration Route, Methyldopa - Concentration/Dosage 250 Mg, Methyldopa - Concentration/Dosage 500 Mg, Coated Tablet Pharmaceutical Form, Metoprolol, Tartrate - Concentration/Dosage 1Mg/Ml, Presentation In Ampoule With 5Ml, Via Administration Intravenous / Intramuscular, Succinate - Concentration/Dosage 25 Mg, Pharmaceutical Form Controlled Release Tablet, Milrinone, Lactate - Concentration/Dosage 1 Mg/Ml, Pharmaceutical Form Injectable Solution, Vial-Ampule Presentation Form, Intravenous Administration Route, Nifedipine - Concentration/Dosage 10 Mg, Delayed Release Tablet Pharmaceutical Form, Nifedipine - Concentration/Dosage 20 Mg, Prolonged Release Tablet Pharmaceutical Form, Nitroglycerin - Concentration/Dosage 5 Mg/Ml, Ampoule Presentation Form With 10Ml, Intravenous Administration Route, Sodium Nitroprusside - Concentration/Dosage 25 Mg/Ml, Pharmaceutical Form For Injectable Solution, Presentation Form 2Ml Vial-Ampule, Intravenous Administration Route, Norepinephrine - Concentration/Dosage 2 Mg/4Ml, Ampoule Presentation Form With 4Ml, Intravenous Administration Route. Reserve Quota According To Decree 8747/2020., Propatylnitrate - Concentration/Dosage 10 Mg, Propranolol, Hydrochloride - Concentration/Dosage 40 Mg, Simvastatin - Concentration/Dosage 20 Mg
|
